Archive for June 12th, 2012

Chatroom has been disabled

Jun 12, 2012 No Comments by

I’ve decided to remove the chatroom from BioPharmCatalyst due to the high cost involved in maintaining the chatroom and a feeling that it doesn’t fit in with the philosophy of the website of giving unbiased tools for readers to use in their investing and trading decisions. I will continue to explore avenues to improve the website […]

Articles Read more

BIOD reverse split. ZIOP initiates Phase 3 SCLC trial. BPAX plans further LibiGel trials + AVNR PLX news

Jun 12, 2012 No Comments by

Biodel Inc. (Nasdaq:BIOD) announced that it will effect a one-for-four reverse split prior to the start of trading on June 12, 2012. The number of authorized shares of common stock will be adjusted to 25m. ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced that has initiated its Phase 3 MATISSE study (Multicenter Adaptive Trial Investigating Small cell lung cancer Survival Endpoints), of palifosfamide for the […]

Daily News Read more